Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Infectious Disease
•
Neurology
•
Neuromuscular
Do patients on eculizumab or ravulizumab require repeat vaccination against meningococcal infection after a certain interval?
Answer from: at Academic Institution
Yes, CDC recommends a booster Men B vaccine 1 year after completion of series and then every 2-3 years thereafter, and booster Men C every 5 years.
Sign in or Register to read more
16983
Related Questions
Is history of GBS a contraindication for all future flu vaccines?
Which novel immunomodulatory treatment(s) do you consider in refractory seronegative bulbar-predominant myasthenia?
Would you avoid combining JAK inhibitors with IVIG given the risk of thromboembolism?
How do you counsel anesthesia providers in perioperative management of patients with limb girdle muscular dystrophy?
Does receiving IVIG confound the result of SPEP and/or UPEP?
How do you treat congenital paramyotonia symptoms?
What workup do you initiate for thoracic outlet syndrome?
How do you evaluate patients with suspicion of notalgia paresthetica?
Does pregabalin contribute to esophagitis or gastroparesis?
Do you send only serum paraneoplastic panels or also include CSF evaluation in patients with concern for paraneoplastic neuropathy?